Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 12, 2017 - Issue 7
Submit an article Journal homepage
507
Views
3
CrossRef citations to date
0
Altmetric
Review

Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development

Boris KubuschokDepartment of Internal Medicine II, Klinikum Augsburg, Augsburg, Germany;Department of Hematology and Oncology, University of Saarland Medical School, Homburg, Germany
&
Martin TrepelDepartment of Internal Medicine II, Klinikum Augsburg, Augsburg, Germany;Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyCorrespondence[email protected]
Pages 733-745 | Received 21 May 2016, Accepted 08 May 2017, Published online: 07 Jun 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F. Elliott, Thomas Witzig, Laurie H. Sehn, Marek Trnĕný, Umberto Vitolo, Maurizio Martelli, Margaret Foster, Barbara Wendelberger, Grzegorz Nowakowski & Donald A. Berry. (2022) PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & Lymphoma 63:12, pages 2816-2831.
Read now

Articles from other publishers (2)

Una Glamoclija, Lejla Mahmutovic, Esma Bilajac, Violeta Soljic, Katarina Vukojevic & Mirza Suljagic. (2022) Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells. Frontiers in Pharmacology 13.
Crossref
Marina Bacac, Sara Colombetti, Sylvia Herter, Johannes Sam, Mario Perro, Stanford Chen, Roberta Bianchi, Marine Richard, Anne Schoenle, Valeria Nicolini, Sarah Diggelmann, Florian Limani, Ramona Schlenker, Tamara Hüsser, Wolfgang Richter, Katharine Bray-French, Heather Hinton, Anna Maria Giusti, Anne Freimoser-Grundschober, Laurent Lariviere, Christiane Neumann, Christian Klein & Pablo Umaña. (2018) CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies. Clinical Cancer Research 24:19, pages 4785-4797.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.